IL36G and neoplasm: Furthermore, gene therapy delivering IL-1 family member IL-F9/IL-36γ induces HEV and TLS formation in mouse colon carcinomas in association with the development of superior T cell-mediated anti-tumor immunity and tumor growth suppression (11).